日本語 >>
TOP page
Journal
Presentation
Belonging society
(Last updated : 2024-09-04 09:11:48)
Munenori Takaoka
Department
Kawasaki Medical School Kawasaki Medical School, Department of General Surgery,
Position
Associate Professor
■
Journal
1.
2017/11
Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma.
2.
2017/10
Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma.
3.
2017/04
False-Positive Cases of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomographic Scans in Metastasis of Esophageal Cancer
4.
2017/02
A Case of Cholesterol Crystal Embolization with Hemorrhagic Imntestinal Ulcer
5.
2017/02
Evaluation of intra-ductal cancer spread using contrast superb micro-vascular imaging(SMI)-a case report-
6.
2015/06
Skin Tube Reconstruction for Esophageal Defects due to Postoperative Complications: Applying a skin flap in esophageal
resection and reconstruction
7.
2015/06
TAE226,a Bis-Anilio Pyrimidine Compound,Inhibits the EGFR-Mutant Kinase Including T790M Mutant to Show Anti-Tumor Effect on EGFR-Mutant Non-Small Cell Lung Cancer Cells
8.
2015/05
Feasibility of oral administration of S-1 as adjuvant chemotherapy in gastric cancer: 4-week S-1 administration followed by 2-week rest vs. 2-week administration followed by 1-week rest
9.
2014/12
A case report of isolated presacral squamous cell carcinoma developd four years after gastrectomy
10.
2014/12
Amino acid signaling in the intestine: The roles of glutamine, leucine and arginine
11.
2013/11
Gastric function preserving esophagectomy for esophageal cancer
12.
2013/08
Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancers
13.
2013/01
Antiproliferative effect of a novel mTOR inhibitor temsirolimus contributes to the prolonged survival of orthotopic esophageal cancer-bearing mice.
14.
2013/01
Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer
15.
2012/12
A case of cecal volvulus in a cerebral palsy patient: Usefulness of multidetector computed tomography for preoperative diagnosis
16.
2012/11
Anti-tumor effect of a novel FAK inhibitor TAE226 against human oral squamous cell carcinoma.
17.
2012/09
Antiproliferative effect of the HSP90 inhibitor NVP-AUY922 is determined by the expression of PTEN in esophageal cancer.
18.
2012/08
Jejunal interposition reconstruction with a stomach preserving esophagectomy improves postoperative weight loss and reflux symptoms for esophageal cancer patients.
19.
2012/07
Esophageal cancer exhibits resistance to a novel IGF-1R inhibitor NVP-AEW541 with maintained RAS-MAPK activity.
20.
2012/07
Giant gastrointestinal stromal tumor of the jejunum resected after treatmentwith imatinib
21.
2012/07
Oral administration of FAK inhibitor TAE226 inhibits the progression of peritoneal dissemination of colorectal cancer.
22.
2012/04
Strong anti-tumor effect of NVP-AUY922, a novel Hsp90 inhibitor, on non-small cell lung cancer.
23.
2010/09
Antitumor effect of temsirolimus against oral squamous cell carcinoma associated with bone destruction.
24.
2010/07
HSP90 and its inhibitors.
25.
2010/04
Can it become a potential therapeutic target?
26.
2010/04
RAD001 offers a therapeutic intervention through inhibition of mTOR as a potential strategy for esophageal cancer.
27.
2010/02
The establishment of a new mouse model with orthotopic esophageal cancer showing the esophageal stricture.
Display 5 items
Display all(27)
■
Presentation
1.
2018/09/28
Targeted silencing of SOX2 by an ATF showed antitumor effect in lung and esophageal squamous cell carcinoma (ポスター掲示)
2.
2018/09/16
False positive cases of FDG-PET/CT in metastasis of esophageal squamous cell carcinoma (ポスター掲示)
3.
2018/09/05
Lymph node metastasis in middle and lower bile duct cancer:Prognostic impact and distribution (ポスター掲示,一般)
4.
2018/06/08
A surgical case of jejunal aberrant pancreas containing high-grade pancreatic intraepithelial neoplasia(PanIN3) (ポスター掲示,一般)
5.
2018/06/08
Remnant pancreatic resection for pancreatic cancer (ポスター掲示,一般)
6.
2018/04/16
Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma (ポスター掲示,一般)
7.
2017/06/14
Laparocopic ventral hernia repair with fascial defect closure (ポスター掲示,一般)
8.
2017/06/09
A surgical case of metachronous liver metastasis of hepatoid adenocarcinoma of the stomach (ポスター掲示,一般)
9.
2017/06/08
Prognostic factors for resected adenocarcinomas of the ampulla of vater (ポスター掲示,一般)
10.
2017/04/03
Development of a novel targeted therapy for malignant mesothelioma carcinoma by a midkine inhibitor. (ポスター掲示)
11.
2016/10/06
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma (口頭,一般)
12.
2016/06/15
Suturing Techniques for Closure of Fascial Defect during Laparoscopic Ventral Hernia Repairs:a review of the literature (ポスター掲示)
13.
2016/04/18
Sox2 silencing upregulates CDKNIA and suppresses growth of lung squamous cell carcinoma (ポスター掲示)
14.
2016/03/17
Minilaparoscopic inguinal hernia repair(m-TAPP)with 5mm laparoscope and 2mm grasper:An alternative to traditional TAPP (ポスター掲示)
15.
2015/06/03
Micro-laparoscopic Inguinal Hernia Repair (M-Tapp): An Alternative to Traditional Tapp (ポスター掲示,一般)
16.
2015/04/21
Developmemt of a Sox2 targeting therapy for the treatment of lung squamous cell carcinoma (ポスター掲示,一般)
17.
2015/04/20
Esphageal cancer exhibits a resistance to the chemical of IGF-1R with a maintained Ras-MAPK activity (ポスター掲示,一般)
18.
2015/03/18
Remnant pancreatic resection for pancreatic cancer (ポスター掲示,一般)
19.
2014/09/27
Sox2 silencing suppresses cell growth and colony formation of
squamous cell lung cancer (ポスター掲示,シンポジウム・ワークショップ パネル(公募))
20.
2014/06/26
TAPP USING NEEDLESCOPIC INSTRUMENTS FOR INGUINAL HERNIA IN ADULTS. (ポスター掲示,一般)
21.
2014/04/06
Effective use of MDK/Midkine and MEK inhibitor to treat KRas mutated pulmonary adenocarcinoma cells (ポスター掲示,一般)
22.
2014/04/04
Inhibition of the growth factor midkine by a novel small molecule compound to treat pulmonary adenocarcinoma (口頭,一般)
23.
2013/10/05
Inhibition of Midkine by a novel small molecule compound to treat non-small cell lung cancer (口頭,一般)
24.
2013/06/19
THE USEFULNESS OF THE LEFT LATERAL DECUBITUS POSITION IN THE THORACOSCOPIC ESOPHAGECTOMY
25.
2013/04/08
Development of novel targeted therapies for non-small cell carcinoma by novel Midkine inhibitors (ポスター掲示,一般)
26.
2012/09/21
Identification of novel Midkine inhibitors for the treatment of non-small cell lung cancer (口頭,一般)
27.
2012/04/04
Targeting KRAS lung cancer in vivo by pulmonary surfactant-medicated gene transfer (ポスター掲示,一般)
28.
2012/04/02
HSP90 inhibitor NVP-AUY922 exhibits the potent antiproliferative effect in gastrointestinal cancer cells with a lack of PTEN expression (ポスター掲示,一般)
29.
2011/10/03
Anti-tumor effect in lung cancer by a combination treatment of novel HDAC inhibitors : SL142 or SL325 and retinoic acids (口頭,一般)
30.
2011/04/04
Antitumor effect in human lung cancer by a combination treatment of novel histone deacetylase inhibitors: SL142 or SL325 and retinoic acids. (ポスター掲示)
31.
2011/04/04
Inhibition of mammalian target of rapamycin(mTOR)signaling by Temsirolimus as a potential therapeutic strategy for esophageal cancer treatment. (ポスター掲示)
32.
2010/09/23
Experimental approach to control peritoneal dissemination of colon cancer by targeting FAK. (シンポジウム・ワークショップ パネル(その他))
33.
2010/09/22
Esophageal cancer exhibits a resistance to a novel IGF-1R inhibitor NVP-AEW541 with a maintained Ras-MAPK activity. (ポスター掲示,一般)
34.
2010/04/20
The establishment of a new mouse model with orthotopic esophageal cancer showing the esophagostenosis
35.
2010/04/19
N-cadherin down-rgulation has antitumor effects in esophageal cancer
36.
2010/04/19
The anti-tumor effect of TAE226 , dual inhibitor of fak and IGF-IR , on non-small-cell lung cancer with EGFR mutain
Display 5 items
Display all(36)
■
Belonging society
1.
1996~
Japan Surgical Society
2.
1997~
The Japanese Society of Gastroenterological Surgery
3.
2000~
American Association for Cancer Research
4.
2000~
Japanese Cancer Association
5.
2006~
Japan Gastroenterological Endoscopy Society